Potential Therapeutics Targeting Upstream Regulators and Interactors of EHMT1/2
10.3390/cancers14122855
Saved in:
Main Authors: | Ang, Gareth Chin Khye, Gupta, Amogh, Surana, Uttam, Yap, Shirlyn Xue Ling, Taneja, Reshma |
---|---|
Other Authors: | PHARMACOLOGY |
Format: | Article |
Published: |
MDPI AG
2022
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/227223 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
EHMT2 epigenetically suppresses Wnt signaling and is a potential target in embryonal rhabdomyosarcoma
by: Pal, Ananya, et al.
Published: (2020) -
EHMT1/EHMT2 in EMT, cancer stemness and drug resistance: emerging evidence and mechanisms
by: Nachiyappan, A, et al.
Published: (2022) -
EHMT1 promotes tumor progression and maintains stemness by regulating ALDH1A1 expression in alveolar rhabdomyosarcoma
by: Nachiyappan, Alamelu, et al.
Published: (2022) -
Ehmt2 epigenetically suppresses wnt signaling and is a potential target in embryonal rhabdomyosarcoma
by: Pal, A., et al.
Published: (2021) -
Transmembrane activator and CAML interactor (TACI) : another potential target for immunotherapy of multiple myeloma?
by: Xu, Shengli, et al.
Published: (2021)